Can a short alcohol program help people on opioid treatment?
NCT ID NCT07342504
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a short, tailored alcohol intervention is practical and well-liked by people who are taking buprenorphine for opioid use and also drink alcohol. About 60 adults will take part. The goal is to see if this approach could work in a larger future study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Notre Dame
RECRUITINGNotre Dame, Indiana, 46556, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tool better measure opioid withdrawal?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Hidden risk: could opioid misuse be overlooked in cancer care?
- Giving patients a voice in methadone care: a new approach under the microscope
- Can a sleep pill boost success in opioid treatment?
- Can a brain zapping headset curb relapse in addiction?